Back to Search

MARK FRATTINI, MD

MD

Medical Oncology Physician

NPI: 1881665669Individual

Specialties, Licenses & Credentials

Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

227450(NY)

Research & Publications (20)

Strategy for incorporating molecular and cytogenetic markers into acute myeloid leukemia therapy.
PMID 19176197·J Natl Compr Canc Netw·2008
6-review
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients.
PMID 18669866·Ann Oncol·2009
8-other
An exo-cell assay for examining real-time gamma-secretase activity and inhibition.
PMID 19490610·Mol Neurodegener·2009
8-other
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.
PMID 19117336·Hum Mutat·2009
8-other
An overview of the epidermal growth factor receptor fluorescence in situ hybridisation challenge in tumour pathology.
PMID 19052028·J Clin Pathol·2009
6-review
Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant.
PMID 19293803·Br J Cancer·2009
8-other
PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.
PMID 19223544·Cancer Res·2009
8-other
Epidemiology and molecular biology of gastrointestinal stromal tumors (GISTs): a population-based study in the South of Switzerland, 1999-2005.
PMID 18785120·Histol Histopathol·2008
8-other
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.
PMID 19001320·J Clin Oncol·2008
4-observational
Multiple mechanisms contribute to Schizosaccharomyces pombe origin recognition complex-DNA interactions.
PMID 18723846·J Biol Chem·2008
7-preclinical
AKT1(E17K) in human solid tumours.
PMID 18504432·Oncogene·2008
8-other
Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer.
PMID 18395974·Cancer Lett·2008
8-other
PIK3CA cancer mutations display gender and tissue specificity patterns.
PMID 18022911·Hum Mutat·2008
8-other
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients.
PMID 17940504·Br J Cancer·2007
8-other
Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis.
PMID 17785554·Clin Cancer Res·2007
8-other
Phenotype-genotype correlation: challenge of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses.
PMID 16906516·Head Neck·2006
8-other
Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool.
PMID 17108210·Ann N Y Acad Sci·2006
8-other
[Networks: a research and development tool serving to support the evolution of the health system].
PMID 17094686·Sante Publique·2006
8-other
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis.
PMID 16890597·Gastroenterology·2006
4-observational
Homeodomain-interacting protein kinase-2 restrains cytosolic phospholipase A2-dependent prostaglandin E2 generation in human colorectal cancer cells.
PMID 16467083·Clin Cancer Res·2006
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1275 YORK AVE
NEW YORK, NY 10021

Location

Practice Location

1275 YORK AVE, NEW YORK, NY
(646) 227-3813

Quick Facts

NPI
1881665669
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile